Related Content
Search Google Scholar for:
|
|
Science 27 September 1985:
Vol. 229. no. 4720, pp. 1352 - 1357
DOI: 10.1126/science.2994217
|
|
Articles
Science, Vol 229, Issue 4720, 1352-1357
Copyright © 1985 by American Association for the Advancement of Science
The epidemiology of AIDS: current status and future prospects
JW Curran,
WM Morgan,
AM Hardy,
HW Jaffe,
WW Darrow,
and
WR Dowdle
The reported incidence of acquired immune deficiency syndrome (AIDS) continues to increase in countries throughout the world. On the basis of a polynomial model for extrapolation, the cumulative number of cases diagnosed and reported since 1981 in the United States is expected to double during the next year with over 12,000 additional cases projected to be diagnosed by July 1986. The annual incidence rates for single (never-married) men in Manhattan and San Francisco, intravenous drug users in New York City and New Jersey, and persons with hemophilia A ranged from 261 to 350 per 100,000 population during 1984. For single men aged 25 to 44 years in Manhattan and San Francisco, AIDS was the leading cause of premature mortality in 1984 as measured by years of potential life lost. Infection with HTLV-III/LAV is considerably more common than reported AIDS in high-risk populations and can persist at least for several years, so the presence of specific antibody should be considered presumptive evidence of current infection. The screening of donated blood and plasma for antibody to HTLV-III/LAV and use of safer clotting factor concentrates should greatly reduce HTLV-III/LAV transmission through blood and blood products. Most HTLV-III/LAV infections occur through sexual transmission, use of contaminated needles, and as a result of infected mothers passing the virus to newborns. Continued research commitment is needed to develop an HTLV-III/LAV vaccine and therapy for this infection. In the interim, widespread community efforts are needed to minimize transmission.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Human cytomegalovirus modulation of CCR5 expression on myeloid cells affects susceptibility to human immunodeficiency virus type 1 infection..
- C. A. King, J. Baillie, and J. H. Sinclair (2006)
J. Gen. Virol.
87, 2171-2180
| Abstract »
| Full Text »
| PDF »
- Overcoming the False Dichotomy of Curative vs Palliative Care for Late-Stage HIV/AIDS: "Let Me Live the Way I Want to Live, Until I Can't".
- P. A. Selwyn and M. Forstein (2003)
JAMA
290, 806-814
| Abstract »
| Full Text »
| PDF »
- Confronting the Challenge of AIDS among Adolescents: Directions for Future Research.
- R. J. DiClemente (1993)
Journal of Adolescent Research
8, 156-166
| Abstract »
- Intravenous Drug Use and the AIDS Epidemic: Findings from a 20-City Sample of Arrestees.
- S. Decker and R. Rosenfeld (1992)
Crime Delinquency
38, 492-509
| Abstract »
- Reconstruction and future trends of the AIDS epidemic in the United States.
- R Brookmeyer (1991)
Science
253, 37-42
| Abstract »
| PDF »
- Developing a Community Sample of Gay Men for an Epidemiologic Study of AIDS.
- J. L. MARTIN and L. DEAN (1990)
American Behavioral Scientist
33, 546-561
- Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses.
- P Lusso, F di Marzo Veronese, B Ensoli, G Franchini, C Jemma, S. DeRocco, V. Kalyanaraman, and R. Gallo (1990)
Science
247, 848-852
| Abstract »
| PDF »
- The Emergence of Adolescents as a Risk Group for Human Immunodeficiency Virus Infection.
- R. J. DiClemente (1990)
Journal of Adolescent Research
5, 7-17
| Abstract »
- A Demographic and Epidemiological Study of New York State Inmate AIDS Mortalities, 1981-1987.
- R. Gido (1989)
The Prison Journal
69, 27-32
| PDF »
- HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation.
- J. Zack, A. Cann, J. Lugo, and I. Chen (1988)
Science
240, 1026-1029
| Abstract »
| PDF »
- AIDS: an international perspective.
- P Piot, F. Plummer, F. Mhalu, J. Lamboray, J Chin, and J. Mann (1988)
Science
239, 573-579
| Abstract »
| PDF »
- Epidemiology of HIV infection and AIDS in the United States.
- J. Curran, H. Jaffe, A. Hardy, W. Morgan, R. Selik, and T. Dondero (1988)
Science
239, 610-616
| Abstract »
| PDF »
- The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.
- A. Fauci (1988)
Science
239, 617-622
| Abstract »
| PDF »
- Human Immunodeficiency Virus Infection and the Acquired Immune Deficiency Syndrome: A Review.
- M. T. Schechter and R. A. Coates (1988)
Sexual Abuse: A Journal of Research and Treatment
1, 205-225
| Abstract »
| PDF »
- Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.
- M Siekevitz, S. Josephs, M Dukovich, N Peffer, F Wong-Staal, and W. Greene (1987)
Science
238, 1575-1578
| Abstract »
| PDF »
- AIDS: Legal and Policy Implications of the Application of Traditional Disease Control Measures.
- W. J. Curran, M. E. Clark, and L. Gostin (1987)
J. Law Med. Ethics
15, 27-35
| PDF »
- AIDS and the Criminal Law.
- M. A. Field and K. M. Sullivan (1987)
J. Law Med. Ethics
15, 46-60
| PDF »
- The Clinical Challenges of AIDS and HIV Infection.
- K. H. Mayer (1986)
J. Law Med. Ethics
14, 281-289
| PDF »
- AIDS in Africa: an epidemiologic paradigm.
- T. Quinn, J. Mann, J. Curran, and P Piot (1986)
Science
234, 955-963
| Abstract »
| PDF »
- Isolation of a new human retrovirus from West African patients with AIDS.
- F Clavel, D Guetard, F Brun-Vezinet, S Chamaret, M. Rey, M. Santos-Ferreira, A. Laurent, C Dauguet, C Katlama, C Rouzioux, et al. (1986)
Science
233, 343-346
| Abstract »
| PDF »
- Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein.
- L. Lasky, J. Groopman, C. Fennie, P. Benz, D. Capon, D. Dowbenko, G. Nakamura, W. Nunes, M. Renz, and P. Berman (1986)
Science
233, 209-212
| Abstract »
| PDF »
|
|
